LEAWOOD, Kan., March 8, 2017 /PRNewswire/ -- Aratana
Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company
focused on the licensing, development and commercialization of
innovative biopharmaceutical products for companion animals, plans
to present at the Barclays Capital Global Healthcare Conference on
Thursday, March 16, 2017 at
9:00 a.m. ET in Miami.
Interested parties may listen to the webcast live or
access the audio link for up to 90 days after the meeting.
Presentation slides from the conference will also be available in
the Aratana Investor Room.
About Aratana Therapeutics
Aratana Therapeutics is a
pet therapeutics company focused on licensing, developing and
commercializing innovative biopharmaceutical products for companion
animals. Aratana believes that it can leverage the investment in
the human biopharmaceutical industry to bring therapeutics to pets
in a capital and time efficient manner. The Company's pipeline
includes therapeutic candidates targeting pain, inappetence,
cancer, viral diseases, allergy and other serious medical
conditions. Aratana believes the development and
commercialization of these therapeutics will permit veterinarians
and pet owners to manage pets' medical needs safely and
effectively, resulting in longer and improved quality of life for
pets. For more information, please visit www.aratana.com.
Contacts
For investor inquires:
Craig Tooman
ctooman@aratana.com
(913) 353-1026
For media inquiries:
Rachel
Reiff
rreiff@aratana.com
(913) 353-1050
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/aratana-therapeutics-to-present-at-barclays-capital-global-healthcare-conference-300420518.html
SOURCE Aratana Therapeutics, Inc.